# The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

> **NCT06041399** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital of Wenzhou Medical University** · enrollment: 1400 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathy

## Interventions

- **DRUG:** hypoglycemic Agents(metformin)
- **DRUG:** lipid-lowering drug(Statin)

## Key facts

- **NCT ID:** NCT06041399
- **Lead sponsor:** First Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02-01
- **Primary completion:** 2022-12-18
- **Final completion:** 2025-01-02
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06041399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06041399, "The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06041399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*